GS — The Goldman Sachs Group, Inc.

The market is constructive but not enthusiastic: the stock is ~10% below its 52-week high, the consensus rating is Hold, and price targets ($1,202 average, $1,325 high) imply upside without urgency. The M&A/trading backdrop is supportive, but the stock is not cheap versus its own history, so sentiment is balanced rather than bullish.

From 2023 through 2025, quarterly revenue was generally steady in the $28-32B range while EPS drifted from ~$5.50 in late 2023 to $12-14 in 2025. The reported Q1 2026 revenue of $17.2B is a clear anomaly relative to the surrounding quarters and is flagged as a possible divestiture/acquisition/reporting distortion. Q2 2026 was exceptionally strong: revenue $38.4B (+23% YoY), operating income $11.5B (+132% YoY), and EPS $20.98 (+92% YoY). Excluding the Q1 data break, the trend is one of margin expansion and rising earnings power, not structural deterioration.

At $1,040.87, GS trades at 15.9x TTM EPS of $69.89 and about 14.8x next-FY consensus EPS of $70.23. That is well above its own 5-year average P/E of 13.0x, and price/sales of 2.60x is far above the 5-year average of 1.74x. The PEG of 0.37 looks eye-catching but is driven by a recent EPS surge, not a reliable long-term growth rate. In absolute terms the multiple is not absurd for a top-tier franchise with 17.8% net margin and 13.7% ROE, but relative to its own history, GS is expensive.

The stock is essentially pricing in sustained high-$60s to low-$70s EPS rather than discounting a trough or a breakout. At ~14.8x forward EPS, there is no margin of safety for a cyclical miss. If the M&A/underwriting cycle holds, Q2 2026's $20.98 EPS becomes the new base and the stock can grind higher; if capital markets roll over, EPS could revert toward $55-60 and the multiple could compress, leaving outsized downside from here.

As of 2026-08-27, RSI(14) was 49.97, dead neutral. Price was +0.32% above the 20-day SMA, -1.02% below the 50-day SMA, and +10.56% above the 200-day SMA. This is a range-bound/consolidation setup after a big rally, not an overbought or oversold entry signal. A pullback toward the 50-day or a confirmed breakout above the 52-week high would be cleaner entry points.

• Non-recessionary Fed rate cuts and easier financial conditions are supportive for trading, underwriting, and capital-markets activity.
• Global GDP growth of ~2.8% and U.S. growth of ~2.6%, with global M&A up 48% YoY and mega-deals up 125%, directly feed GS's advisory pipeline.
• High equity valuations make the market more sensitive to labor-market cracks or Fed policy shifts, which would hit trading revenue and multiples.
• Regulatory and capital-requirement scrutiny continues to cap how many turns investors will pay for tier-1 investment bank earnings.
• AI-related dealmaking and corporate portfolio realignment are creating a secular tailwind for investment banking fees.

• Q3 2026 earnings in mid-October — the key test of whether Q2's EPS blowout ($20.98) starts a higher earnings base or marks a cyclical peak.
• Closing and integration of the LCN Capital Partners acquisition, which would expand fee-based asset-management revenue.
• FOMC guidance on rate cuts: a dovish surprise would likely boost trading and IB volumes, while a hawkish surprise would pressure the multiple.

• Capital-markets revenue is cyclical; a sharp slowdown in M&A, IPOs, or trading could push EPS from $70 toward the $55-60 range.
• The stock is expensive versus its own historical P/E and P/S, so de-rating risk is greater than re-rating upside.
• Regulatory capital requirements, litigation, and potential restructuring charges remain structural overhangs for large banks.
• The reported Q1 2026 revenue anomaly creates data noise; if the true earnings trajectory is weaker than Q2 suggests, estimates may be too high.

Goldman is a high-quality cyclical franchise currently enjoying a strong capital-markets tailwind, and Q2 2026's EPS of $20.98 is real evidence that earnings power has stepped up. However, the stock already trades at a premium to its own valuation history, and the technical picture shows no momentum edge. It is a good business to own on weakness, but not a compelling new buy at $1,041.

Applied a 15.0x multiple to next-fiscal-year consensus EPS of $70.23, about two turns above GS's 5-year average P/E of 13.0x to reflect higher margins, improved ROE, and the current M&A/underwriting tailwind. 15.0 x $70.23 = $1,053.45, implying the stock is close to intrinsic value at $1,040.87.